Restorelle 522 Study

Currently, CARE is proud to be involved in a major international multicentre research project Restorelle ® Transvaginal Mesh versus native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study.  

Information regarding this project is available at https://clinicaltrials.gov/ct2/show/NCT02162615. This project has ethics approval from St. Vincent’s Hospital HREC with reference Number HREC/16/SVH/304.